March 20, 2016
Nucleix Introduced Bladder EpiCheck in the European Association of Urology (EAU) Annual Meeting
Nucleix presented Bladder EpiCheck during the annual meeting of the European Association of Urology (EAU), to expose more than 12,000 urology professionals to the upcoming launch of Bladder EpiCheck in the EU. The meeting took place in Munich during March
June 16, 2014
Cancer screening company Nucleix raises $5m
Orbimed Israel and Zohar Zisapel participated in the financing round. Nucleix, which is developing a test for early detection of bladder cancer, has raised more than $5 million in an investment round led by venture capital firm OrbiMed Advisors LLC.